Indian Journal of PsychiatryIndian Journal of Psychiatry
Home | About us | Current Issue | Archives | Ahead of Print | Submission | Instructions | Subscribe | Advertise | Contact | Login 
    Users online: 1165 Small font sizeDefault font sizeIncrease font size Print this article Email this article Bookmark this page
  Instructions 
  Search 
  IPS 
  My preferences 

 


This article has been cited by
1
Sanne Y. Smith-Apeldoorn,Jolien K. E. Veraart,Robert A. Schoevers
.2019;()3
[DOI]
2Clozapine for the treatment of schizophrenia
Eric Fakra,Jean-Michel Azorin
Expert Opinion on Pharmacotherapy.2012;13(13)1923
[DOI]
3Clozapine for the treatment of schizophrenia
William Spaulding,Robert Johnson,Jeffrey Nolting,Amanda Messman
Expert Opinion on Pharmacotherapy.2012;13(13)252
[DOI]
4Use of very-high-dose olanzapine in treatment-resistant schizophrenia
J.-M. Batail,B. Langrée,G. Robert,S. Bleher,M.-C. Verdier,E. Bellissant,B. Millet,D. Drapier
Schizophrenia Research.2014;159(2-3)411
[DOI]
5The usefulness of monitored therapy using Clozapine concentration in the blood serum for determining drug dose in Polish schizophrenic patients
Jadwiga Piwowarska,Maria Radziwon-Zaleska,Martyna Dmochowska,Ewa Szepietowska,Halina Matsumoto,Grazyna Sygitowicz,Andrzej Pilc,Jacek Lukaszkiewicz
Pharmacological Reports.2016;68(6)1120
[DOI]
6Combined treatment with a selective PDE10A inhibitor TAK-063 and either haloperidol or olanzapine at subeffective doses produces potent antipsychotic-like effects without affecting plasma prolactin levels and cataleptic responses in rodents
Kazunori Suzuki,Akina Harada,Hirobumi Suzuki,Clizia Capuani,Annarosa Ugolini,Mauro Corsi,Haruhide Kimura
Pharmacology Research & Perspectives.2018;6(1)e00372
[DOI]
7Genetic association analysis of N-methyl-d-aspartate receptor subunit geneGRIN2Band clinical response to clozapine
Danielle L. Taylor,Arun K. Tiwari,Jeffrey A. Lieberman,Steven G. Potkin,Herbert Y. Meltzer,Jo Knight,Gary Remington,Daniel J. Müller,James L. Kennedy
Human Psychopharmacology: Clinical and Experimental.2016;31(2)121
[DOI]
8Differential antibody responses to gliadin-derived indigestible peptides in patients with schizophrenia
R T McLean,P Wilson,D St Clair,C J Mustard,J Wei
Translational Psychiatry.2017;7(5)e1121
[DOI]
9Differential antibody responses to gliadin-derived indigestible peptides in patients with schizophrenia
William D. Spaulding,Robert W. Johnson,Jeffrey R. Nolting,Amanda Collins Messman
Translational Psychiatry.2012;7(5)252
[DOI]
10An examination of neurocognition and symptoms as predictors of post-hospital community tenure in treatment resistant schizophrenia
Anthony O. Ahmed,Christopher F. Murphy,Vassilios Latoussakis,Kelly E. McGovern,Judith English,Andrew Bloch,Donna T. Anthony,Adam J. Savitz
Psychiatry Research.2016;236(5)47
[DOI]
11Clozapine-resistant Schizophrenia: Strategies for the Busy Clinician
Mansi Jain
Indian Journal of Private Psychiatry.2017;11(2)17
[DOI]
12Solubility, solvent effect, molecular simulation and thermodynamic properties of clozapine in twelve pure solvents
Yi Gong,Yueru Wang,Zibo Huang,Jiao sha,Yu Li,Tao Li,Baozeng Ren
The Journal of Chemical Thermodynamics.2021;158(2)106398
[DOI]
13Patient characteristics, burden and pharmacotherapy of treatment-resistant schizophrenia: results from a survey of 204 US psychiatrists
Christoph U. Correll,Thomas Brevig,Cecilia Brain
BMC Psychiatry.2019;19(1)106398
[DOI]
14Electroconvulsive therapy in treatment of resistant schizophrenia: biological markers of efficacy and safety
M. V. Ivanov,D. S. Zubov
Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova.2019;119(3)92
[DOI]
15The impact of paliperidone palmitate long-acting injection on hospital admissions in a mental health setting
Nikola Nikolic,Natalie Page,Adil Akram,Maha Khan
International Clinical Psychopharmacology.2017;32(2)95
[DOI]
16Boîte à outil translationnelle du psychiatre face aux situations de résistances et complexes
A. Amad
French Journal of Psychiatry.2018;1(2)S7
[DOI]
17Outcome definitions and clinical predictors influence pharmacogenetic associations between HTR3A gene polymorphisms and response to clozapine in patients with schizophrenia
A. P. Rajkumar,B. Poonkuzhali,A. Kuruvilla,A. Srivastava,M. Jacob,K. S. Jacob
Psychopharmacology.2012;224(3)441
[DOI]
18Does the Starting of Clozapine Influence Coprescription of Other Medications?
Sandeep Grover,Chandrima Naskar,Subho Chakrabarti
Journal of Clinical Psychopharmacology.2021;41(2)148
[DOI]
19A study of anti-gliadin antibodies in first-episode patients with schizophrenia among a Chinese population
Hua Yang,Yaling Jiang,Zhenjian Chen,Jingqing Wu,Chaosen Qiu,Qingyong Meng
Psychiatry Research.2019;272(2)454
[DOI]
20Bioequivalence of Generic and Brand Name Clozapine in Korean Schizophrenic Patients: A Randomized, Two-Period, Crossover Study
Young Sup Woo,Hee-Ryung Wang,Bo-Hyun Yoon,Sang-Yeol Lee,Kwang Hun Lee,Jeong Seok Seo,Won-Myong Bahk
Psychiatry Investigation.2015;12(3)356
[DOI]
21Developing the language of futility in psychiatry with care
Willie Pienaar
South African Journal of Psychiatry.2016;22(1)7
[DOI]
22Psychological Autopsy: Reconstructing the Mystery of Suicide
Abdul Majid,Ajaz A Suhaff,Abdul Walid Khan
Indian Journal of Private Psychiatry.2017;11(2)24
[DOI]